Create a postgraduate-level seminar presentation on “Pneumonia in Infants and Children” for an Emergency Medicine residency audience at an academic medical institute in India. Use Tintinalli’s Emergency Medicine and Rosen’s Emergency Medicine as the core textbook references, but supplement them with current guidelines and recent evidence (2024–2026). Cover the following: - Definition and classification - Epidemiology and burden, including Indian/LMIC context - Age-specific etiology and pathogens - Pathophysiology and why infants deteriorate rapidly - Clinical presentation and age-specific signs - Tachypnea, work of breathing and hypoxemia - Severity assessment and danger signs - Differential diagnosis, especially bronchiolitis, asthma and foreign body aspiration - Investigations: CBC, CRP, procalcitonin, blood cultures, chest X-ray and when each is indicated - Chest X-ray findings in pediatric pneumonia - Lung ultrasound (LUS): indications, technique, signs of pneumonia, dynamic air bronchograms, consolidation, pleural effusion and comparison with CXR - Molecular diagnostics and multiplex respiratory PCR - Biomarkers and their limitations - Admission and PICU criteria - Oxygen therapy and respiratory support - HFNC: indications, mechanisms, monitoring and failure criteria - Antibiotic indications and empiric treatment - Antibiotic stewardship and appropriate duration of therapy - Complicated pneumonia, parapneumonic effusion and empyema - Chest tube drainage, fibrinolytics and VATS - Necrotizing pneumonia and lung abscess - Pneumonia in infants <3 months - Aspiration pneumonia - TB and other important causes relevant to India - Prevention and vaccination IMPORTANT: Include a dedicated “Recent Advances / What’s New” section Focus specifically on developments from 2024–2026, including: 1. 2026 IDSA/PIDS pediatric CAP guideline 2. Increasing role of lung ultrasound 3. LUS vs chest X-ray evidence 4. Biomarker-guided diagnosis, particularly procalcitonin/CRP 5. Multiplex molecular diagnostics 6. Antibiotic stewardship and shorter antibiotic courses 7. HFNC and newer approaches to pediatric respiratory support 8. Updated management of parapneumonic effusion/empyema, including small-bore chest tubes 9. RSV prevention, including maternal vaccination and long-acting monoclonal antibodies such as nirsevimab/clesrovimab where applicable 10. AI-assisted chest X-ray/LUS interpretation 11. Host-response/RNA signatures for bacterial vs viral pneumonia 12. Future directions in precision diagnosis and treatment Clearly distinguish established clinical practice from emerging/investigational technologies. Guidelines/references to prioritize Use and cite the latest versions of: - IDSA/PIDS 2026 Clinical Practice Guideline for Community-Acquired Pneumonia in Infants and Children - WHO 2024 Guideline on management of pneumonia and diarrhoea in children up to 10 years - WHO 2024 guideline/recommendations for serious bacterial infections in infants 0–59 days -
Create a postgraduate-level seminar presentation on “Pneumonia in Infants and Children” for an Emergency Medicine residency audience at an academic medical institute in India.
Use Tintinalli’s Emergency Medicine and Rosen’s Emergency Medicine as the core textbook references, but supplement them with current guidelines and recent evidence (2024–2026).
Cover the following:
- Definition and classification
- Epidemiology and burden, including Indian/LMIC context
- Age-specific etiology and pathogens
- Pathophysiology and why infants deteriorate rapidly
- Clinical presentation and age-specific signs
- Tachypnea, work of breathing and hypoxemia
- Severity assessment and danger signs
- Differential diagnosis, especially bronchiolitis, asthma and foreign body aspiration
- Investigations: CBC, CRP, procalcitonin, blood cultures, chest X-ray and when each is indicated
- Chest X-ray findings in pediatric pneumonia
- Lung ultrasound (LUS): indications, technique, signs of pneumonia, dynamic air bronchograms, consolidation, pleural effusion and comparison with CXR
- Molecular diagnostics and multiplex respiratory PCR
- Biomarkers and their limitations
- Admission and PICU criteria
- Oxygen therapy and respiratory support
- HFNC: indications, mechanisms, monitoring and failure criteria
- Antibiotic indications and empiric treatment
- Antibiotic stewardship and appropriate duration of therapy
- Complicated pneumonia, parapneumonic effusion and empyema
- Chest tube drainage, fibrinolytics and VATS
- Necrotizing pneumonia and lung abscess
- Pneumonia in infants <3 months
- Aspiration pneumonia
- TB and other important causes relevant to India
- Prevention and vaccination
IMPORTANT: Include a dedicated “Recent Advances / What’s New” section
Focus specifically on developments from 2024–2026, including:
1. 2026 IDSA/PIDS pediatric CAP guideline
2. Increasing role of lung ultrasound
3. LUS vs chest X-ray evidence
4. Biomarker-guided diagnosis, particularly procalcitonin/CRP
5. Multiplex molecular diagnostics
6. Antibiotic stewardship and shorter antibiotic courses
7. HFNC and newer approaches to pediatric respiratory support
8. Updated management of parapneumonic effusion/empyema, including small-bore chest tubes
9. RSV prevention, including maternal vaccination and long-acting monoclonal antibodies such as nirsevimab/clesrovimab where applicable
10. AI-assisted chest X-ray/LUS interpretation
11. Host-response/RNA signatures for bacterial vs viral pneumonia
12. Future directions in precision diagnosis and treatment
Clearly distinguish established clinical practice from emerging/investigational technologies.
Guidelines/references to prioritize
Use and cite the latest versions of:
- IDSA/PIDS 2026 Clinical Practice Guideline for Community-Acquired Pneumonia in Infants and Children
- WHO 2024 Guideline on management of pneumonia and diarrhoea in children up to 10 years
- WHO 2024 guideline/recommendations for serious bacterial infections in infants 0–59 days
-
Created using ChatSlide
This guide covers the recognition and assessment of pediatric pneumonia, starting with a case of an infant in respiratory distress. It discusses definitions, the burden of the disease, and age-specific signs. The diagnosis and treatment section includes targeted tests and management pathways, emphasizing antibiotic stewardship. Finally, it addresses complications such as effusion and recent advances in treatment guidelines, concluding with prevention strategies and key take-home messages.